Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 141 | 248 | +107 |
| Shares | 88.6M | 122.6M | +34.0M (+38.3%) |
| Value | $665.7M | $4.95B | +$4.29B (+644.0%) |
New holders (124)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Showing the largest 100 of 124 by value.
Sold out (17)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Salem Investment Counselors Inc | 346,850 | $2.60M |
| Jacobs Levy Equity Management, Inc | 136,979 | $1.03M |
| Samsara BioCapital, LLC | 135,573 | $1.02M |
| Exchange Traded Concepts, LLC | 121,455 | $912.1K |
| Dynamic Technology Lab Private Ltd | 66,576 | $500.0K |
| Alps Advisors Inc | 42,630 | $320.2K |
| Zacks Investment Management | 36,100 | $271.1K |
| Stoneridge Investment Partners LLC | 16,867 | $127.0K |
| Caxton Associates LLP | 15,168 | $113.9K |
| Landscape Capital Management, L.L.C. | 13,196 | $99.1K |
| Oppenheimer & Co Inc | 12,466 | $93.6K |
| Polymer Capital Management (US) LLC | 10,144 | $76.2K |
| Caitong International Asset Management Co., Ltd | 651 | $4.89K |
| Optiver Holding B.V. | 456 | $3.42K |
| Rise Advisors, LLC | 445 | $3.34K |
| ZRC Wealth Management, LLC | 281 | $2.11K |
| LGT Financial Advisors LLC | 50 | $376 |